Okay, let's tackle this question. The patient is a newborn with cyanosis starting on day three, a systolic murmur, and echocardiography showing cyanotic heart disease. The question is about which drug can be given to prolong life until intervention.

First, I need to recall the common cyanotic heart diseases in newborns. Tetralogy of Fallot (TOF) comes to mind. TOF typically presents with cyanosis after the first few days when the ductus arteriosus closes. The systolic murmur is due to the overriding aorta and pulmonary stenosis.

The key here is that when the ductus arteriosus is open, blood can bypass the right ventricular outflow obstruction. Once it closes, cyanosis worsens. So, to delay this closure, we can use a prostaglandin. Prostaglandin E1 (PGE1) is used to keep the ductus open.

Looking at the options, if one of them is a prostaglandin, that's the answer. The other options might include beta-blockers, diuretics, or other drugs. Beta-blockers might be used in other conditions like supraventricular tachycardia but not here. Diuretics aren't indicated for cyanotic heart disease. Oxygen therapy could help with cyanosis but doesn't address the underlying issue of ductal closure.

So the correct answer is the prostaglandin, like Alprostadil. The other options don't maintain ductal patency. Clinical pearl: Remember that in TOF, PGE1 is given to keep the ductus open until surgical correction can be done.

**Core Concept**
This question tests knowledge of **prostaglandin E1 (PGE1) use in cyanotic heart disease** due to ductal-dependent circulation. Cyanotic lesions like Tetralogy of Fallot (TOF) rely on a patent ductus arteriosus (PDA) to maintain systemic oxygenation in early life. Closing the PDA exacerbates cyanosis.

**Why the Correct Answer is Right**
**Prostaglandin E1 (PGE1)** is administered to **maintain ductal patency**, ensuring left-to-right shunting in ductal-dependent lesions. In TOF, the ductus arteriosus allows blood to bypass the right ventricular outflow tract obstruction. When the ductus closes (typically by day 3), systemic oxygenation drops, worsening cyanosis. PGE1 delays this closure until surgical intervention (e.g., Blalock-Taussig shunt or complete repair) can be performed.

**Why Each Wrong Option is Incorrect**
**Option A:** *Beta-blockers* reduce myocardial oxygen demand but are not used in ductal-dependent lesions.
**Option B:** *Oxygen therapy* may worsen TOF by increasing pulmonary vascular resistance, diverting more blood to the lungs and exacerbating cyanosis.
**Option C:** *Diuretics* are contraindicated in cyanotic heart disease due to risk of volume depletion and reduced cardiac output.

**Clinical Pearl**
**Remember: "PGE1 keeps the ductus open for ductal-dependent cyanotic lesions like TOF."** Avoid oxygen in TOF; use PGE1 to stabilize until surgery.

**Correct Answer: C. Prostaglandin

✓ Correct Answer: C. Prostaglandin El